UCB | Profitto Lordo Sulle Vendite



Gross Profit On Sales Cambiamento Data
Alcon AG USD 1.38B 14M 2024-12
Almirall EUR 231.69M 73.09M 2024-06
Amarin USD 16.28M 26.49M 2024-09
argenx SE USD 665.76M 371.88M 2024-12
AstraZeneca USD 12.17B 1.06B 2024-12
Bayer EUR 6.01B 1.13B 2024-12
Galapagos EUR 61.25M 98.68M 2025-03
Genmab DKK 6.1B 837M 2024-12
GlaxoSmithKline GBP 5.56B 57M 2024-12
GRIFOLS EUR 766.49M 39.74M 2024-12
Hikma Pharmaceutical USD 756M 82M 2024-06
Lonza CHF 1.12B 276M 2024-06
Merck EUR 3.1B 45M 2024-12
Novartis USD 10.23B 294M 2024-12
Orion EUR 201.8M 65.5M 2025-03
Recordati EUR 385.12M 1.11M 2024-09
Roche Holding CHF 11.69B 48M 2024-12
Sanofi EUR 10.07B 2.1B 2024-09
UCB EUR 970M 788M 2024-06
Unibail Rodamco EUR 997M 516.9M 2024-12



UCB Profitto Lordo Sulle Vendite - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Apr 2025.